Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India.

Literature DB >> 11372642

Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India.

P Garg, S Sinha, R Chakraborty, S K Bhattacharya, G B Nair, T Ramamurthy, Y Takeda.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2001 PMID： 11372642 PMCID： PMC90520 DOI： 10.1128/AAC.45.5.1605-1606.2001

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

6 in total

1. Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents.

Authors: T Yamamoto; G B Nair; M J Albert; C C Parodi; Y Takeda
Journal: Antimicrob Agents Chemother Date: 1995-01 Impact factor: 5.191

2. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India.

Authors: A K Mukhopadhyay; I Basu; S K Bhattacharya; M K Bhattacharya; G B Nair
Journal: Antimicrob Agents Chemother Date: 1998-01 Impact factor: 5.191

3. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.

Authors: S K Bhattacharya; M K Bhattacharya; P Dutta; D Dutta; S P De; S N Sikdar; A Maitra; A Dutta; S C Pal
Journal: Antimicrob Agents Chemother Date: 1990-05 Impact factor: 5.191

4. Efficacy of norfloxacin and doxycycline for treatment of vibrio cholerae 0139 infection.

Authors: D Dutta; S K Bhattacharya; M K Bhattacharya; A Deb; M Deb; B Manna; A Moitra; A K Mukhopadhyay; G B Nair
Journal: J Antimicrob Chemother Date: 1996-03 Impact factor: 5.790

5. Antibiotic susceptibility testing by a standardized single disk method.

Authors: A W Bauer; W M Kirby; J C Sherris; M Turck
Journal: Am J Clin Pathol Date: 1966-04 Impact factor: 2.493

6. Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults.

Authors: E Gotuzzo; C Seas; J Echevarría; C Carrillo; R Mostorino; R Ruiz
Journal: Clin Infect Dis Date: 1995-06 Impact factor: 9.079

6 in total

18 in total

1. Vibrio cholerae 01 ogawa (Eltor) diarrhoea at Sevagram.

Authors: Prerna Batra; Abhijeet Saha; K Y Vilhekar; P Chaturvedi; D K Mendiratta
Journal: Indian J Pediatr Date: 2006-06 Impact factor: 1.967

2. Spread of cholera with newer clones of Vibrio cholerae O1 El Tor, serotype inaba, in India.

Authors: B Dutta; R Ghosh; N C Sharma; G P Pazhani; N Taneja; A Raychowdhuri; B L Sarkar; S K Mondal; A K Mukhopadhyay; R K Nandy; M K Bhattacharya; S K Bhattacharya; T Ramamurthy
Journal: J Clin Microbiol Date: 2006-09 Impact factor: 5.948

3. Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance.

Authors: Anil Kumar Singh; Rajen Haldar; Debabrata Mandal; Manikuntala Kundu
Journal: Antimicrob Agents Chemother Date: 2006-09-05 Impact factor: 5.191

Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India.

1. Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents.

2. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India.

3. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.

4. Efficacy of norfloxacin and doxycycline for treatment of vibrio cholerae 0139 infection.

5. Antibiotic susceptibility testing by a standardized single disk method.

6. Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults.

1. Vibrio cholerae 01 ogawa (Eltor) diarrhoea at Sevagram.

2. Spread of cholera with newer clones of Vibrio cholerae O1 El Tor, serotype inaba, in India.

3. Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance.

4. Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.

5. Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India.

6. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio cholerae.

7. Role of 6-gingerol in reduction of cholera toxin activity in vitro and in vivo.

8. In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae.

9. Resistance to ceftriaxone in Vibrio cholerae.

10. Tetracycline-resistant Vibrio cholerae O1, Kolkata, India.